Cargando…
Can MicroRNAs Improve the Management of Lung Cancer Patients? A Clinician's Perspective
The treatment of patients with lung cancer is increasingly individualised. Rather than treating lung cancer as a single disease, clinicians are often called upon to consider the precise histology and molecular biology of each tumour in addition to the individual characteristics of each patient. Para...
Autores principales: | Tufman, Amanda, Tian, Fei, Huber, Rudolf Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881097/ https://www.ncbi.nlm.nih.gov/pubmed/24396506 http://dx.doi.org/10.7150/thno.6615 |
Ejemplares similares
-
microRNAs Associated with Carotid Plaque Development and Vulnerability: The Clinician’s Perspective
por: Badacz, Rafał, et al.
Publicado: (2022) -
MicroRNAs in cardiovascular disease: an introduction for clinicians
por: Romaine, Simon P R, et al.
Publicado: (2015) -
Interdisciplinary multimodality management of stage III nonsmall cell lung cancer
por: Huber, Rudolf M., et al.
Publicado: (2019) -
A perspective to weaponize microRNAs against lung cancer
por: Murugan, Dhanashree, et al.
Publicado: (2022) -
MicroRNAs in Lung Cancer Oncogenesis and Tumor Suppression: How it Can Improve the Clinical Practice?
por: Pozza, Daniel Humberto, et al.
Publicado: (2020)